In a word, the U.S. stock vaccine goes a thousand miles. In fact, these should be three questions. Is the epidemic really over? Not vaccinated? Not enough vaccine stock valuations and profits yet?
Look at how the media is reporting, and there's a summary of the previous Moderna news story.
Wall Street Daily:
“The epidemic is over. We still have issues related to the pandemic...” Biden told CBS on the 18th.THE BIDEN ADMINISTRATION IS PROMOTING A NEW VACCINE AGAINST THE CORONAVIRUS STRAIN AND SEEKING NEW FUNDING FROM CONGRESS IN THE AMOUNT OF APPROVAL.Biden was criticized in July 2021 when he signaled the end of the pandemic, while a large number of deaths of COVID-19 patients are still ongoing.
AFP：
“The pandemic is over, we're still facing COVID, and we're still putting a lot of effort into it...” Biden said. However,A few weeks ago, the Biden administration asked Congress to provide $224 in funding to maintain the roadmap for testing and vaccination, in case the fall pandemic could come again。
BBC：
The situation has already improved, according to Fauch. But he also said in a Washington think-tank that the daily death rate remains “unacceptably high.” “If we say we're going to 'coexist with the virus', we're not getting where we need to be right now,” Fauch said. He told me again,New coronavirus variants of 2019 are still possible, especially in the coming winter months.
The United States recently authorized a new vaccine to match the number of Omics currently in the country.